🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 2, randomized, double-blind, placebo-controlled, parallel-g...
Status
Completed
Location
Preferred Research Partners
Start Date
2023-03-02
Trial ID
NCT05686408
Treatments Being Tested
This study investigates brain response to single acute dose of citalopram, ...
Status
Unknown
Location
King's College London
Start Date
2014-12-15
Trial ID
NCT04145076
Treatments Being Tested
Breast cancer is the most common malignancy among females. Nearly 40% of br...
Status
Completed
Location
National Cancer Institute Cairo University
Start Date
2023-06-21
Trial ID
NCT05935059
Treatments Being Tested
The primary purpose of this study is to investigate medication utilization ...
Status
Completed
Location
Pfizer
Start Date
2022-07-04
Trial ID
NCT04446039
COVID-19 is associated with a high risk of complications from the central n...
Status
Recruiting
Location
Anna Klimkiewicz
Start Date
2023-02-17
Trial ID
NCT06012552
Treatments Being Tested
The studies will be conducted in parallel at two sites: the the Mood and An...
Status
Terminated
Location
Stanford Depression Research Clinic at Stanford University School of Medicine
Start Date
2020-10-14
Trial ID
NCT04249596
Treatments Being Tested
The primary object of this study is to confirm the superiority of tianeptin...
Status
Completed
Location
Inje University Paik Hospital
Start Date
2011-03
Trial ID
NCT01309776
Treatments Being Tested
The purpose of this study is to investigate the absorption, metabolic pathw...
Status
Completed
Location
Multiple Locations
Start Date
2009-04
Trial ID
NCT02049697
Treatments Being Tested
One of the main challenges in the treatment of Bipolar Disorder (BD) is to ...
Status
Unknown
Location
Hospital de Clinicas de Porto Alegre
Start Date
2009-03
Trial ID
NCT00879372
Treatments Being Tested